References
- Falcone FH, Zillikens D, Gibbs BF. The 21st century renaissance of the basophil? Current insights into its role in allergic responses and innate immunity. Exp Dermatol 2006;15:855–864.
- Ohnmacht C, Schwartz C, Panzer M, . Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths. Immunity 2010;33:364–374.
- Karasuyama H, Obata K, Wada T, . Newly appreciated roles for basophils in allergy and protective immunity. Allergy 2011;66: 1133–1141.
- Togias AG. Systemic immunologic and inflammatory aspects of allergic rhinitis. J Allergy Clin Immunol 2000;106:247–250.
- Denburg JA, Browman G. Prognostic implications of basophil differentiation in chronic myeloid leukemia. Am J Hematol 1988;27: 110–114.
- Hasford J, Pfirrmann M, Hehlmann R, . A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. J Natl Cancer Inst 1998;90:850–858.
- Valent P, Agis H, Sperr W, . Diagnostic and prognostic value of new biochemical and immunohistochemical parameters in chronic myeloid leukemia. Leuk Lymphoma 2008;49:635–638.
- Falcone FH, Haas H, Gibbs BF. The human basophil: a new appreciation of its role in immune responses. Blood 2000;96:4028–4038.
- Valent P, Schmidt G, Besemer J, . Interleukin-3 is a differentiation factor for human basophils. Blood 1989;73:1763–1769.
- Valent P, Besemer J, Muhm M, . Interleukin 3 activates human blood basophils via high-affinity binding sites. Proc Natl Acad Sci USA 1989;86:5542–5546.
- Valent P, Bettelheim P. Cell surface structures on human basophils and mast cells: biochemical and functional characterization. Adv Immunol 1992;52:333–423.
- Yamaguchi M, Hirai K, Morita Y, . Hemopoietic growth factors regulate the survival of human basophils in vitro. Int Arch Allergy Immunol 1992;97:322–329.
- Zheng X, Karsan A, Duronio V, . Interleukin-3, but not granulocyte-macrophage colony-stimulating factor and interleukin-5, inhibits apoptosis of human basophils through phosphatidylinositol 3-kinase: requirement of NF-kappaB-dependent and -independent pathways. Immunology 2002;107:306–315.
- Yoshimura C, Miyamasu M, Nagase H, . Glucocorticoids induce basophil apoptosis. J Allergy Clin Immunol 2001;108:215–220.
- Schroeder JT, Chichester KL, Bieneman AP. Human basophils secrete IL-3: evidence of autocrine priming for phenotypic and functional responses in allergic disease. J Immunol 2009;182:2432–2438.
- Matsumoto K, Maeda A, Bochner BS, . Induction of apoptosis in human basophils by anti-Fas antibody treatment in vitro. Int Arch Allergy Immunol 2008;146:40–46.
- Schneider E, Tonanny MB, Lisbonne M, . Pro-Th1 cytokines promote Fas dependent apoptosis of immature peripheral basophils. J Immunol 2004;172:5262–5268.
- Florian S, Sonneck K, Czerny M, . Detection of novel leukocyte differentiation antigens on basophils and mast cells by HLDA8 antibodies. Allergy 2006;61:1054–1062.
- Kishi K. A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors. Leuk Res 1985;9:381–390.
- Fisher GH, Rosenberg FJ, Straus SE, . Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995;81:935–946.
- Hartmann K, Wagelie-Steffen AL, von Stebut E, . Fas (CD95, APO-1) antigen expression and function in murine mast cells. J Immunol 1997;159:4006–4014.
- Welker P, Grabbe J, Henz BM. Differential expression of mast cell characteristics in human myeloid cell lines. Exp Dermatol 2004;13: 535–542.
- Fukuda T, Kishi K, Ohnishi Y, . Bipotential cell differentiation of KU-812: evidence of a hybrid cell line that differentiates into basophils and macrophage-like cells. Blood 1987;70:612–619.
- Okano H, Endo T, Shiokawa S, . Hemoglobin synthesis of both adult and fetal types in a human CML cell line. J Biochem 1988;104: 162–164.
- Nakazawa M, Mitjavila MT, Debili N, . KU 812: a pluripotent human cell line with spontaneous erythroid terminal maturation. Blood 1989;73:2003–2013.
- Hartmann K, Beiglböck F, Czarnetzki BM, . Effect of CC chemokines on mediator release from human skin mast cells and basophils. Int Arch Allergy Immunol 1995;108:224–230.
- Yamaguchi A, Gabazza EC, Takei Y, . Role of thrombin in interleukin-5 expression from basophils. Biochem Biophys Res Commun 2008;368:116–120.
- Krauth MT, Mirkina I, Herrmann H, . Midostaurin (PKC412) inhibits immunoglobulin E-dependent activation and mediator release in human blood basophils and mast cells. Clin Exp Allergy 2009;39: 1711–1720.
- Lin WW, Hsieh SL. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer. Biochem Pharmacol 2011;81:838–847.
- Safa AR, Day TW, Wu CH. Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy. Curr Cancer Drug Target 2008;8:37–46.
- Didichenko SA, Spiegl N, Brunner T, . IL-3 induces a Pim1-dependent antiapoptotic pathway in primary human basophils. Blood 2008;112:3949–3958.
- Kalousek I, Brodska B, Otevrelova P, . Actinomycin D upregulates proapoptotic protein Puma and downregulates Bcl-2 mRNA in normal peripheral blood lymphocytes. Anticancer Drugs 2007;18:763–772.
- Park YW, Ji JD, Lee JS, . Actinomycin D renders cultured synovial fibroblasts susceptible to tumour necrosis factor related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Scand J Rheumatol 2003; 32:356–363.
- Ng CP, Bonavida B. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO). Mol Cancer Ther 2002;1:1051–1058.
- Mariani SM, Matiba B, Armandola EA, . Interleukin 1 beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J Cell Biol 1997;137: 221–229.
- Mariani SM, Krammer PH. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage. Eur J Immunol 1998;28:973–982.
- Steegmann JL, Odriozola J, Rodriguez-Salvanes F, . Stage, percentage of basophils at diagnosis, hematologic response within six months, cytogenetic response in the first year: the main prognostic variables affecting outcome in patients with chronic myeloid leukemia in chronic phase treated with interferon-alpha. Haematologica 1999; 84:978–987.
- Charles N, Hardwick D, Daugas E, . Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat Med 2010;16:701–707.
- Ogasawara J, Watanabe-Fukunaga R, Adachi M, . Lethal effect of the anti-Fas antibody in mice. Nature 1993;364:806–809.